The startup develops medical data analytics software that utilizes artificial intelligence and deep learning algorithms for image classification and natural language processing of medical reports. This technology enhances patient outcomes and operational efficiency by enabling healthcare organizations to analyze large datasets and address clinical challenges identified by key opinion leaders.
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare providers face challenges in efficiently and accurately analyzing complex medical data, including radiological images and patient records, which can lead to delays in diagnosis and treatment planning. Manual analysis is time-consuming, prone to human error, and struggles to keep pace with the increasing volume of data.
Solution
InformAI develops AI-driven enterprise software solutions that automate and enhance the analysis of medical data, specifically targeting radiology, radiation oncology, and high-acuity informatics. Their flagship product, RadOncAI, generates optimized radiation therapy plans that precisely target tumors while minimizing exposure to healthy tissues. The company's portfolio also includes TransplantAI, a donor-recipient informatics platform for AI-powered transplant decisions, and SinusAI, which enhances CT imaging diagnostics. InformAI's solutions are designed to improve healthcare quality, safety, and efficiency by addressing specific clinical needs with seamless and scalable AI products.
Target Audience
InformAI's primary customers are healthcare organizations, including hospitals and clinics, particularly those specializing in radiology, radiation oncology, and transplant medicine.
Features
- RadOncAI: AI-driven radiation therapy planning that optimizes tumor targeting and minimizes exposure to adjacent healthy tissues.
- TransplantAI: A donor-recipient informatics platform that enables granular, AI-powered transplant decisions at the point of care.
- SinusAI: AI-enabled CT imaging diagnostics for enhanced precision and efficiency in sinus imaging.
- Enterprise-grade software designed for seamless integration and scalability within existing healthcare systems.
- Solutions designed to unlock value through existing reimbursement frameworks.
- Partnerships with elite medical institutions and channel partners for direct deployment.